Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
शेयरों में रैंक #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
शेयर मूल्य
$0.30780727
मार्केट कैप
$94.19M
बदलाव (1 दिन)
-0.19%
बदलाव (1 वर्ष)
-34.73%
देश
FR
व्यापार Sensorion SA (ALSEN)

श्रेणी

Sensorion SA (ALSEN) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.30 (2026-07-01 को)

दिन का सबसे निम्न समापन मूल्य: $4.88 (2015-04-01 को)
Sensorion SA के स्टॉक मूल्य का इतिहास 2015 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -14.19%
2025 -35.43%
2024 42.20%
2023 21.00%
2022 -80.41%
2021 12.23%
2020 121.36%
2019 -30.56%
2018 -66.86%
2017 -29.31%
2016 -42.01%
2015 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$49.28 -28.51%
DK
$482.59 2.93%
US
$663.74 16.91%
US
$281.36 41.09%
BE
$869.87 55.27%
NL